Capital Fund Management S.A. Legend Biotech Corp Transaction History

Capital Fund Management S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$33.54 - $55.0 $668,787 - $1.1 Million	-19,940 Reduced 54.73%	16,495 $907,000
Q1 2022 May 12, 2022	BUY	$31.02 - $48.18 $1.13 Million - $1.76 Million	36,435 New	36,435 $1.32 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.